We constructed a risk model using HOXA5, PTPN2, WT1, HOXD10, POSTN, ADAMDEC1 and MYBPH expression data from a cohort of patients in TCGA, and found that it had significant prognostic value for ATRX-wt glioma patients. Here, PTPN2 is linked to central nervous system cancer.